FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

19374211000001101: Evoxil 250mg tablets (Kent Pharma (UK) Ltd) 5 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 24-Aug 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2488191000001118 Evoxil 250mg tablets (Kent Pharma (UK) Ltd) 5 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2488201000001116 Evoxil 250mg tablets (Kent Pharma (UK) Ltd) 5 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Evoxil 250mg tablets (Kent Pharma (UK) Ltd) 5 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Evoxil 250mg tablets (Kent Pharma (UK) Ltd) 5 tablet Discontinued indicator Re-marketed true Inferred relationship Existential restriction modifier
Evoxil 250mg tablets (Kent Pharma (UK) Ltd) 5 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Evoxil 250mg tablets (Kent Pharma (UK) Ltd) 5 tablet Is a Levofloxacin 250mg tablets 5 tablet true Inferred relationship Existential restriction modifier
Evoxil 250mg tablets (Kent Pharma (UK) Ltd) 5 tablet Has AMP Evoxil 250mg tablets (Kent Pharma (UK) Ltd) true Inferred relationship Existential restriction modifier
Evoxil 250mg tablets (Kent Pharma (UK) Ltd) 5 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Evoxil 250mg tablets (Kent Pharma (UK) Ltd) 5 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Evoxil 250mg tablets (Kent Pharma (UK) Ltd) 5 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Evoxil 250mg tablets (Kent Pharma (UK) Ltd) 5 tablet Has specific active ingredient Levofloxacin hemihydrate false Inferred relationship Existential restriction modifier
Evoxil 250mg tablets (Kent Pharma (UK) Ltd) 5 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Evoxil 250mg tablets (Kent Pharma (UK) Ltd) 5 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Levofloxacin true Inferred relationship Existential restriction modifier
Evoxil 250mg tablets (Kent Pharma (UK) Ltd) 5 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Evoxil 250mg tablets (Kent Pharma (UK) Ltd) 5 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Evoxil 250mg tablets (Kent Pharma (UK) Ltd) 5 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Evoxil 250mg tablets (Kent Pharma (UK) Ltd) 5 tablet Discontinued indicator Discontinued AMPP(qualifier value) false Inferred relationship Existential restriction modifier
Evoxil 250mg tablets (Kent Pharma (UK) Ltd) 5 tablet Has specific active ingredient Levofloxacin hemihydrate true Inferred relationship Existential restriction modifier
Evoxil 250mg tablets (Kent Pharma (UK) Ltd) 5 tablet Has basis of strength substance Levofloxacin true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start